Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|14|12|1490-1500

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1490-1500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Therapeutic Approaches in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3668-3683

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 15, Iss. 18, 2009-06 ,pp. : 2074-2086

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor Necrosis Factor Blockade for Treatment of Inflammatory Bowel Disease: Efficacy and Safety

By  

Current Molecular Pharmacology, Vol. 3, Iss. 3, 2010-11 ,pp. : 145-152

Bentham Science Publishers

Access to resources Recommend Favorite

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease

By Ulbrich H.   Eriksson E.E.   Lindbom L.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 12, 2003-12 ,pp. : 640-647

Elsevier

Access to resources Recommend Favorite

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease

By Mitsuyama Keiichi   Sata Michio  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 3, 2008-03 ,pp. : 301-312

Informa Healthcare

Access to resources Recommend Favorite